Fore Bio

“Form Bio... Spun out in 2022 with a $30M Series A led by JAZZ Venture Partners”

“Form Bio computational life sciences platform, Colossal spinout. Spun out in 2022 with a $30M Series A led by JAZZ Venture Partners.”

“Colossal Biosciences is seeking to raise at a valuation of $20–30 billion, doubling from its January 2025 valuation of $10.2 billion in roughly 18 months.”

“Fore Bio ($67.4M)”